Current Illinois CancerCare Clinical Trals

Metastatic


S2107

Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer


WF-1806

Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer


Search Again

WordPress PopUp Plugin